Page last updated: 2024-10-27

fluconazole and Infective Endocarditis

fluconazole has been researched along with Infective Endocarditis in 73 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery."8.82Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. ( Athan, E; Hughes, A; Lye, DC; O'Brien, D, 2005)
" On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas."7.74Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. ( Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V, 2008)
"An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months."7.73Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005)
"In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C."7.71Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001)
"We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis."7.70Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999)
"Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C."7.69Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD, 1996)
"Amphotericin B (AmB) and fluconazole, administered intraperitoneally for 7 days, were compared in a rabbit model for Candida albicans endocarditis."7.69Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. ( Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P, 1996)
"A case of active prosthetic valve infective endocarditis (PVE) due to Candida glabrata was successfully treated by the systemic administration of fluconazole."7.69The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. ( Kawachi, Y; Maruyama, Y; Mayumi, H; Nakashima, A; Nishida, T; Tokunaga, K; Tokunaga, S; Yasui, H, 1994)
"An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B."7.68Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. ( Cassone, A; Chirletti, P; De Bernardis, F; Martino, P; Micozzi, A; Pontieri, E; Venditti, M, 1992)
"Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C."7.68Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Imhoff, T; Li, C; Witt, MD, 1993)
"Reported here is the case of a 72-year-old man who was diagnosed with Candida glabrata prosthetic mitral valve endocarditis and treated successfully with fluconazole plus caspofungin after he refused and was determined unfit for surgery."4.82Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review. ( Athan, E; Hughes, A; Lye, DC; O'Brien, D, 2005)
"The serum Fungitell assay was used to trend (1→3)-β-D-glucan in a patient with Candida endocarditis to determine treatment effectiveness with fluconazole, to provide an appropriate end date for antifungal therapy, and to survey infection suppression while off treatment."3.85(1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis. ( Brown, M; Goldfarb, I; Johnson, T; Saling, C; Slim, J; Szabela, M, 2017)
" On days 40 and 47, respectively, antifungal therapy was modified to liposomal Amphotericin B combined with Fluconazole 6 mg/kg/day for 4 weeks, resulting in complete resolution of the mycetomas."3.74Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates. ( Christofidou, M; Darzentas, A; Dimitriou, G; Giannakopoulos, I; Karatza, AA; Mantagos, SP; Marangos, M; Pavlou, V, 2008)
" The patient has no identified sequelae at 6-month follow-up and continues on long-term fluconazole therapy for candida endocarditis."3.73Survival of candida sepsis in extracorporeal membrane oxygenation. ( Ibsen, LM; Minette, MS, 2005)
"An addicted, intravenous drug user was treated for Candida albicans tricuspid valve endocarditis with high dose fluconazole for 8 months, without relapse after 30 months."3.73Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole. ( Julander, I; Thalme, A; Westling, K, 2005)
"In vitro time-kill studies and a rabbit model of endocarditis and pyelonephritis were used to define the impact that the order of exposure of Candida albicans to fluconazole (FLC) and amphotericin B (AMB), as sequential and combination therapies, had on the susceptibility of C."3.71Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis. ( Banerjee, P; Chen, G; Kaw, P; Liu, W; Louie, A; Miller, MH, 2001)
"We compared the efficacies of fluconazole (Flu), amphotericin B (AmB), and 5-fluorocytosine (5FC) monotherapies with the combination of Flu plus 5FC and Flu plus AmB in a rabbit model of Candida albicans endocarditis, endophthalmitis, and pyelonephritis."3.70Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d ( Drusano, GL; Liu, QF; Liu, W; Louie, A; Mayers, M; Miller, DA; Miller, MH; Sucke, AC, 1999)
"Amphotericin B (AmB) and fluconazole, administered intraperitoneally for 7 days, were compared in a rabbit model for Candida albicans endocarditis."3.69Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits. ( Carbon, C; Chemlal, K; Farinotti, R; Joly, V; Saint-Julien, L; Seta, N; Yeni, P, 1996)
"A case of active prosthetic valve infective endocarditis (PVE) due to Candida glabrata was successfully treated by the systemic administration of fluconazole."3.69The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case. ( Kawachi, Y; Maruyama, Y; Mayumi, H; Nakashima, A; Nishida, T; Tokunaga, K; Tokunaga, S; Yasui, H, 1994)
"Amphotericin B (1 mg/kg of body weight, intravenous) and fluconazole (100 mg/kg, intraperitoneal) were compared in the prophylaxis of experimental Candida endocarditis caused by drug-susceptible, non-C."3.69Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Ghannoum, MA; Kim, E; Witt, MD, 1996)
"An unusual case of catheter-related right-sided endocarditis, endophthalmitis, and extensive folliculitis, apparently caused by a single DNA biotype of Candida albicans, was successfully treated with a 6-month course of fluconazole plus two intravitreous doses of amphotericin B."3.68Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis. ( Cassone, A; Chirletti, P; De Bernardis, F; Martino, P; Micozzi, A; Pontieri, E; Venditti, M, 1992)
"Amphotericin B and fluconazole were compared for the treatment of experimental Candida endocarditis caused by Candida tropicalis and C."3.68Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains. ( Bayer, AS; Imhoff, T; Li, C; Witt, MD, 1993)
"Endophthalmitis is often treated with fluconazole or voriconazole, and the echinocandins are increasingly used, instead of amphotericin B, as initial therapy for osteomyelitis and endocarditis before step-down therapy to oral azole agents."2.52Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis. ( Kauffman, CA, 2015)
" However, successful therapy with long-term administration of oral fluconazole has been reported for five patients."2.39Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature. ( Amidi, M; Keys, TF; McMahon, D; Nguyen, MH; Nguyen, ML; Yu, VL, 1996)
"Fungal endocarditis was confirmed by culturing of the resected vegetation showing mixed growth of Candida albicans and Candida tropicalis, although three consecutive blood cultures were negative for Candida species."1.39Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser. ( Abbasi, K; Anvari, MS; Badali, H; Boroumand, M; Fesharaki, SH; Haghani, I; Kargar, ML; Meis, JF; Mousavi, B, 2013)
"Candida endocarditis is extremely rare in term neonates, and gall bladder involvement due to candidemia has never been reported amongst neonates and infants."1.38Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis. ( Garg, A; Goyal, VK; Jajoo, M; Kumar, V, 2012)
"Micafungin was started, patient responded, and fungemia cleared."1.36Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy. ( Afonso, L; Bhargava, A; Chopra, A; Chopra, T; Dhar, S; Kumar, S; Sobel, JD, 2010)
"Endocarditis is uncommon in infants and is exceptionally related to Candida albicans on pulmonary banding."1.35[Candida albicans endocarditis after pulmonary artery banding]. ( Acar, P; Dulac, Y; Kreitmann, B; Mansir, T; Paranon, S; Talvard, M, 2009)
"Endocarditis is an uncommon complication of invasive candidiasis."1.31Candida endocarditis in a premature infant. ( Mogyorósy, G; Nagy, A; Soós, G, 2000)
"Medical treatment of fungal endocarditis on prosthetic valves can be successful in selected cases."1.30A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone. ( Kozelj, M; Lejko-Zupanc, T, 1997)
"A 57-year-old male was treated for fungal endocarditis caused by Candida parapsilosis which precipitated severe cardiac valve vegetation and insufficiency."1.30A case report of Candida parapsilosis endocarditis. ( Inoue, Y; Kawada, S; Ueda, T; Yozu, R, 1998)
"Fungal endocarditis is considered an absolute indication for valve replacement surgery."1.29Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. ( Hinthorn, DR; Klotz, SA; Zahid, MA, 1994)
"Aspergillus endocarditis has been considered as a fatal disease because of the difficulty of diagnosis and treatment."1.29[Two cases of Aspergillus endocarditis after cardiac surgery in childhood]. ( Kawasaki, S; Komai, Y; Naitoh, Y; Noguchi, Y; Takagaki, Y, 1996)

Research

Studies (73)

TimeframeStudies, this research(%)All Research%
pre-19901 (1.37)18.7374
1990's24 (32.88)18.2507
2000's28 (38.36)29.6817
2010's19 (26.03)24.3611
2020's1 (1.37)2.80

Authors

AuthorsStudies
Sheikh, T1
Tomcho, JC1
Awad, MT1
Zaidi, SR1
Slim, J1
Saling, C1
Szabela, M1
Brown, M1
Johnson, T1
Goldfarb, I1
Rivoisy, C1
Vena, A1
Schaeffer, L1
Charlier, C1
Fontanet, A2
Delahaye, F1
Bouza, E2
Lortholary, O2
Munoz, P2
Lefort, A2
Ha, MV1
Choy, MS1
McCoy, D1
Fernandez, N1
Suh, JS1
Siciliano, RF1
Gualandro, DM1
Sejas, ONE1
Ignoto, BG1
Caramelli, B1
Mansur, AJ1
Sampaio, RO1
Pierrotti, LC1
Barbosa, G1
Golebiovski, W1
Weksler, C1
Lamas, C1
Fortes, NRQ1
Fortes, CQ1
Tarasoutchi, F1
Strabelli, TMV1
Agnelli, C1
Guinea, J1
Valerio, M1
Escribano, P1
Hernández-Torres, A1
García-Vázquez, E1
Laso-Ortiz, A1
Herrero-Martínez, JA1
Gómez-Gómez, J1
Fesharaki, SH1
Haghani, I1
Mousavi, B1
Kargar, ML1
Boroumand, M1
Anvari, MS1
Abbasi, K1
Meis, JF1
Badali, H1
Garcia, J1
Soch, K1
Matthew, E1
Surani, S1
Horseman, MA1
Anil Kumar, V1
Francis, E1
Sreehari, S1
Raj, B1
Gardiner, BJ1
Slavin, MA1
Korman, TM1
Stuart, RL1
Rivera, NT1
Bray, N1
Wang, H1
Zelnick, K1
Osman, A1
Vicuña, R1
Costa, A1
Lahmers, S1
Barry, SL1
Stanton, J1
Stern, JA1
Toyoda, S1
Tajima, E1
Fukuda, R1
Masawa, T1
Inami, S1
Amano, H1
Arikawa, T1
Yoshida, A1
Hishinuma, A1
Inoue, T1
Bressieux-Degueldre, S1
Sekarski, N1
Di Bernardo, S1
Kauffman, CA1
Marti, J1
Talvard, M1
Paranon, S1
Dulac, Y1
Mansir, T1
Kreitmann, B1
Acar, P1
Izumi, K1
Hisata, Y1
Hazama, S1
Chopra, T1
Bhargava, A1
Kumar, S1
Chopra, A1
Dhar, S1
Afonso, L1
Sobel, JD1
Smego, RA1
Ahmad, H1
Chartier, L1
Sendid, B1
Wolff, M1
Mainardi, JL1
Podglajen, I1
Desnos-Ollivier, M1
Bretagne, S1
Jajoo, M1
Kumar, V1
Goyal, VK1
Garg, A1
Kaygusuz, I1
Mulazimoglu, L1
Cerikcioglu, N1
Toprak, A1
Oktay, A1
Korten, V1
Marchetti, O2
Moreillon, P2
Entenza, JM2
Vouillamoz, J1
Glauser, MP2
Bille, J2
Sanglard, D2
Aaron, L1
Therby, A1
Viard, JP1
Lahoulou, R1
Dupont, B1
Kaloterakis, A1
Rizos, I1
Goumas, G1
Filiotou, A1
Barbetseas, J1
Papathanasiou, S1
Toutouzas, P1
Schelenz, S1
Gransden, WR1
Yeaman, MR1
Cheng, D1
Desai, B1
Kupferwasser, LI1
Xiong, YQ1
Gank, KD1
Edwards, JE1
Bayer, AS4
Prabhu, RM1
Orenstein, R1
del Castillo, M1
Wainsztein, N1
Klein, F1
Manganello, S1
Orellana, N1
Nevado, J1
De Alarcón, A1
Hernández, A1
Westling, K1
Thalme, A1
Julander, I1
Hariya, A1
Naruse, Y1
Kobayashi, T1
Endo, M1
Ikeda, Y1
Yoshii, T1
Momomura, S1
Ishiwata, S1
Maehara, A1
Minette, MS1
Ibsen, LM1
Lye, DC1
Hughes, A1
O'Brien, D1
Athan, E1
du Plessis, FA1
Helbing, WA1
Bogers, AJ1
Salamon, SA1
Fuursted, K1
Egeblad, H1
Petersen, E1
Ott, P1
Karatza, AA1
Dimitriou, G1
Marangos, M1
Christofidou, M1
Pavlou, V1
Giannakopoulos, I1
Darzentas, A1
Mantagos, SP1
Nishida, T1
Mayumi, H1
Kawachi, Y1
Tokunaga, S1
Maruyama, Y1
Nakashima, A1
Yasui, H1
Tokunaga, K1
Zahid, MA1
Klotz, SA1
Hinthorn, DR1
Cancelas, JA1
Lopez, J1
Cabezudo, E1
Navas, E1
Garcia Laraña, J1
Jimenez Mena, M1
Diz, P1
Perez de Oteyza, J1
Villalon, L1
Sanchez-Sousa, A1
Witt, MD2
Imhoff, T1
Li, C1
Czerwiec, FS1
Bilsker, MS1
Kamerman, ML1
Bisno, AL1
Wells, CJ1
Leech, GJ1
Lever, AM1
Wansbrough-Jones, MH1
Kawasaki, S1
Naitoh, Y1
Takagaki, Y1
Komai, Y1
Noguchi, Y1
Chemlal, K1
Saint-Julien, L1
Joly, V2
Farinotti, R1
Seta, N1
Yeni, P1
Carbon, C2
Fukui, T1
Suehiro, S1
Shibata, T1
Sasaki, Y1
Minamimura, H1
Hattori, H1
Kumano, H1
Kishita, H1
Kim, E1
Ghannoum, MA2
Nguyen, MH1
Nguyen, ML1
Yu, VL1
McMahon, D1
Keys, TF1
Amidi, M1
Sanati, H1
Ramos, CF1
Lejko-Zupanc, T1
Kozelj, M1
Inoue, Y1
Yozu, R1
Ueda, T1
Kawada, S1
Roel, JE1
Gamba, A1
Curone, M1
Pescio, A1
Bruno, C1
Finquelievich, J1
Ariffin, H1
Ariffin, W1
Tharam, S1
Omar, A1
de Bruyne, J1
Lin, HP1
Louie, A2
Liu, W2
Miller, DA1
Sucke, AC1
Liu, QF1
Drusano, GL1
Mayers, M1
Miller, MH2
Roger, PM1
Boissy, C1
Gari-Toussaint, M1
Foucher, R1
Mondain, V1
Vandenbos, F1
le Fichoux, Y1
Michiels, JF1
Dellamonica, P1
Mogyorósy, G1
Soós, G1
Nagy, A1
Kaw, P1
Banerjee, P1
Chen, G1
Nurozler, F1
Argenziano, M1
Oz, MC1
Naka, Y1
Saito, Y1
Takahashi, M1
Sato, A1
Katsuki, T1
Ikeda, U1
Shimada, K1
Liang, JD1
Fang, CT1
Chen, YC1
Chang, SC1
Luh, KT1
Posteraro, B1
Valentini, P1
Delogu, A1
De, RG1
Boccacci, S1
Sanguinetti, M1
Nacci, A1
Sopo, SM1
Ranno, O1
Morace, G1
Fadda, G1
Jones, JM1
Sarsam, MA1
Clarke, MA1
Hedderwick, SA1
Hernández, JA1
Gonzalez-Moreno, M1
Llibre, JM1
Aloy, A1
Casan, CM1
Venditti, M1
De Bernardis, F1
Micozzi, A1
Pontieri, E1
Chirletti, P1
Cassone, A2
Martino, P2
Yamamoto, W1
Ino, T1
Sakurabayashi, I1
Ide, H1
Yaginuma, T1
Martinez-Lacasa, J1
Maña, J1
Niubó, R1
Rufi, G1
Saez, A1
Fernández-Nogués, F1
Roupie, E1
Darmon, JY1
Brochard, L1
Saada, M1
Rekik, N1
Brun-Buisson, C1
Meloni, G1
Isalska, BJ1
Stanbridge, TN1

Reviews

9 reviews available for fluconazole and Infective Endocarditis

ArticleYear
[Candida sp endocarditis. Experience in a third-level hospital and review of the literature].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2013, Volume: 26, Issue:1

    Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Bacteria

2013
Rare infection of implantable cardioverter-defibrillator lead with Candida albicans: case report and literature review.
    Therapeutic advances in cardiovascular disease, 2014, Volume: 8, Issue:5

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Defibrillators, Implantable; Echinocandins; Echoca

2014
Complications of Candidemia in ICU Patients: Endophthalmitis, Osteomyelitis, Endocarditis.
    Seminars in respiratory and critical care medicine, 2015, Volume: 36, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Echinocandins; Echocardiography; Endocarditi

2015
The role of fluconazole in the treatment of Candida endocarditis: a meta-analysis.
    Medicine, 2011, Volume: 90, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida albicans; Candidemia; Candidiasis; Dose-R

2011
Isolated native tricuspid valve Candida endocarditis in a non-drug-addicted patient: case report and review of the literature.
    The Journal of heart valve disease, 2003, Volume: 12, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Debridement; Echocardiography; Endocarditis; Flucona

2003
Candida glabrata prosthetic valve endocarditis treated successfully with fluconazole plus caspofungin without surgery: a case report and literature review.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:11

    Topics: Acute Kidney Injury; Aged; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Caspofu

2005
[Successful surgical treatment for fungal endocarditis involving the aortic valve: report of a case].
    Kyobu geka. The Japanese journal of thoracic surgery, 1996, Volume: 49, Issue:10

    Topics: Antifungal Agents; Aortic Valve; Aortic Valve Insufficiency; Combined Modality Therapy; Endocarditis

1996
Candida prosthetic valve endocarditis: prospective study of six cases and review of the literature.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996, Volume: 22, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; H

1996
Successful treatment of Candida albicans endocarditis in a child with leukemia--a case report and review of the literature.
    Singapore medical journal, 1999, Volume: 40, Issue:8

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Child, Preschool; Drug Therapy, Combination; Endocar

1999

Other Studies

64 other studies available for fluconazole and Infective Endocarditis

ArticleYear
    BMJ case reports, 2020, Nov-17, Volume: 13, Issue:11

    Topics: Administration, Intravenous; Aftercare; Aged, 80 and over; Antifungal Agents; Aortic Valve; Candida

2020
(1→3)-β-D-Glucan Assay in Monitoring Response to Anti-Fungal Therapy in Fungal Endocarditis.
    The Journal of heart valve disease, 2017, Volume: 26, Issue:2

    Topics: Aged; Antifungal Agents; beta-Glucans; Biomarkers; Candida glabrata; Candidiasis; Drug Monitoring; E

2017
Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 03-05, Volume: 66, Issue:6

    Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Management; Endocarditis; Fem

2018
Candida catenulata Candidaemia and Possible Endocarditis in a Cirrhotic Patient Successfully De-escalated to Oral Fluconazole.
    Journal of clinical pharmacy and therapeutics, 2018, Volume: 43, Issue:6

    Topics: Abdominal Pain; Administration, Oral; Adult; Antifungal Agents; Candida; Candidemia; Endocarditis; F

2018
Outcomes in patients with fungal endocarditis: A multicenter observational cohort study.
    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2018, Volume: 77

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Echinocandins; Endocarditis; Female; Fluconazole;

2018
Infectious endocarditis caused by Candida glabrata: evidence of in vivo development of echinocandin resistance.
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2019, Volume: 32, Issue:4

    Topics: Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Echino

2019
Endocarditis due to a co-infection of Candida albicans and Candida tropicalis in a drug abuser.
    Journal of medical microbiology, 2013, Volume: 62, Issue:Pt 11

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida albicans; Candida tropicalis; Candidiasis; Coinfec

2013
Endocarditis caused by Candida dubliniensis.
    The American journal of the medical sciences, 2013, Volume: 346, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Endocarditis; Fluconazole; H

2013
Tricuspid valve mycetoma in an infant successfully treated by excision and complex tricuspid valve repair followed by fluconazole therapy.
    Surgical infections, 2014, Volume: 15, Issue:2

    Topics: Antifungal Agents; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Infant; Male; Mycetoma;

2014
Hampered by historical paradigms--echinocandins and the treatment of Candida endocarditis.
    Mycoses, 2014, Volume: 57, Issue:5

    Topics: Anidulafungin; Antifungal Agents; Candida; Echinocandins; Endocarditis; Fluconazole; Humans; Male; M

2014
Fungal pericarditis and endocarditis secondary to porcupine quill migration in a dog.
    Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology, 2014, Volume: 16, Issue:4

    Topics: Animals; Antifungal Agents; Dog Diseases; Dogs; Endocarditis; Fluconazole; Foreign Bodies; Male; Myc

2014
Early surgical intervention and optimal medical treatment for Candida parapsilosis endocarditis.
    Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:4

    Topics: Aged; Amphotericin B; Antifungal Agents; Aortic Valve; Candida; Candidiasis; Endocarditis; Fluconazo

2015
Fungal endocarditis after hybrid periventricular closure of muscular ventricular septal defect by Amplatzer occluder in a child.
    Circulation, 2015, Feb-10, Volume: 131, Issue:6

    Topics: Administration, Oral; Candidiasis; Caspofungin; Child, Preschool; Echinocandins; Endocarditis; Fluco

2015
Candida parapsilosis endocarditis in aged patient.
    European journal of internal medicine, 2009, Volume: 20, Issue:1

    Topics: Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Therapy, Combination; Endocarditis;

2009
[Candida albicans endocarditis after pulmonary artery banding].
    Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2009, Volume: 16, Issue:8

    Topics: Administration, Oral; Aneurysm, False; Aneurysm, Infected; Antifungal Agents; Candidiasis; Caspofung

2009
A rare case of infective endocarditis complicated by Trichosporon asahii fungemia treated by surgery.
    Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 2009, Volume: 15, Issue:5

    Topics: Anti-Bacterial Agents; Antifungal Agents; Aortic Valve; Combined Modality Therapy; Echocardiography;

2009
Candida kefyr endocarditis in a patient with hypertrophic obstructive cardiomyopathy.
    The American journal of the medical sciences, 2010, Volume: 339, Issue:2

    Topics: Aged; Antifungal Agents; Candidiasis; Cardiomyopathy, Hypertrophic; Echinocandins; Endocarditis; Fem

2010
Diagnosis, management and outcome of Candida endocarditis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:4

    Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibodies, Fungal; Antifungal Agents; Anti

2012
Candida tropicalis infection in a term neonate with gall bladder masses and infective endocarditis.
    Asian Pacific journal of tropical medicine, 2012, Volume: 5, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Candida tropicalis; Candidiasis; Endocarditis; Fluconazole; Gallb

2012
An unusual native tricuspid valve endocarditis caused by Candida colliculosa.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2003, Volume: 9, Issue:4

    Topics: Aged; Amphotericin B; Candida; Candidiasis; Endocarditis; Fluconazole; Humans; Male; Tricuspid Valve

2003
Fungicidal synergism of fluconazole and cyclosporine in Candida albicans is not dependent on multidrug efflux transporters encoded by the CDR1, CDR2, CaMDR1, and FLU1 genes.
    Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5

    Topics: Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Tra

2003
Successful medical treatment of Candida albicans in mechanical prosthetic valve endocarditis.
    Scandinavian journal of infectious diseases, 2003, Volume: 35, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Therapy, Combination; E

2003
Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period.
    Mycoses, 2003, Volume: 46, Issue:9-10

    Topics: Antifungal Agents; Brain Abscess; Candidiasis; Cross Infection; Drug Resistance, Fungal; Endocarditi

2003
Susceptibility to thrombin-induced platelet microbicidal protein is associated with increased fluconazole efficacy against experimental endocarditis due to Candida albicans.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:8

    Topics: Animals; Antifungal Agents; Blood Proteins; Candida albicans; Candidiasis; Colony Count, Microbial;

2004
Failure of caspofungin to treat brain abscesses secondary to Candida albicans prosthetic valve endocarditis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Oct-15, Volume: 39, Issue:8

    Topics: Adult; Amphotericin B; Antifungal Agents; Brain Abscess; Candida albicans; Candidiasis; Caspofungin;

2004
[Treatment with caspofungin of Candida tropicalis endocarditis resistant to fluconazol].
    Medicina, 2004, Volume: 64, Issue:2

    Topics: Aged; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echi

2004
Caspofungin: a new therapeutic option for fungal endocarditis.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:3

    Topics: Adult; Antifungal Agents; Candidiasis; Caspofungin; Echinocandins; Endocarditis; Fluconazole; Humans

2005
Candida albicans tricuspid valve endocarditis in an intravenous drug addict: successful treatment with fluconazole.
    Scandinavian journal of infectious diseases, 2005, Volume: 37, Issue:4

    Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Humans; Mid

2005
[Fungal endocarditis found at onset of lower limb acute aortic occlusion; report of a case].
    Kyobu geka. The Japanese journal of thoracic surgery, 2005, Volume: 58, Issue:9

    Topics: Acute Disease; Antifungal Agents; Aortic Diseases; Arterial Occlusive Diseases; Candidiasis; Combine

2005
Survival of candida sepsis in extracorporeal membrane oxygenation.
    Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2005, Volume: 6, Issue:6

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Endocarditis; Extracorporeal Memb

2005
Excision of the tricuspid valve in a baby with Candida endocarditis.
    Cardiology in the young, 2007, Volume: 17, Issue:5

    Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Failure; Humans; Infant; Ni

2007
Candida albicans tricuspid and pulmonic valve endocarditis: challenge of relapsing risk and role of combined medical treatment and surgery.
    Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:6-7

    Topics: Adult; Candida albicans; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Diseases; Heart

2007
Successful resolution of cardiac mycetomas by combined liposomal Amphotericin B with Fluconazole treatment in premature neonates.
    European journal of pediatrics, 2008, Volume: 167, Issue:9

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Combinations; Endocarditis; Female; Fluconazole

2008
The efficacy of fluconazole in treating prosthetic valve endocarditis caused by Candida glabrata: report of a case.
    Surgery today, 1994, Volume: 24, Issue:7

    Topics: Aged; Aortic Valve Insufficiency; Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Hu

1994
Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis.
    Chest, 1994, Volume: 105, Issue:5

    Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Fluconazole; Fungemia; Heart V

1994
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
    Bone marrow transplantation, 1994, Volume: 13, Issue:3

    Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Endocarditis; Female; Fluc

1994
Comparison of fluconazole and amphotericin B for treatment of experimental Candida endocarditis caused by non-C. albicans strains.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:9

    Topics: Amphotericin B; Animals; Candida; Candidiasis; Endocarditis; Female; Fluconazole; Heart; Injections,

1993
Long-term survival after fluconazole therapy of candidal prosthetic valve endocarditis.
    The American journal of medicine, 1993, Volume: 94, Issue:5

    Topics: Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Middle Aged; Prosthesi

1993
Treatment of native valve Candida endocarditis with fluconazole.
    The Journal of infection, 1995, Volume: 31, Issue:3

    Topics: Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Follow-Up Studies; Heart Valve Di

1995
[Two cases of Aspergillus endocarditis after cardiac surgery in childhood].
    Kyobu geka. The Japanese journal of thoracic surgery, 1996, Volume: 49, Issue:8 Suppl

    Topics: Antifungal Agents; Aspergillosis; Child, Preschool; Endocarditis; Female; Fluconazole; Humans; Male;

1996
Comparison of fluconazole and amphotericin B for treatment of experimental Candida albicans endocarditis in rabbits.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:1

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Colony Count, Microbial; Endocarditis; Fluc

1996
Comparison of fluconazole and amphotericin B in prophylaxis of experimental Candida endocarditis caused by non-C. albicans strains.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Drug Administration Schedule; Endocarditis;

1996
Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:6

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Disease Models, Animal; D

1997
A case of recurrent Candida parapsilosis prosthetic valve endocarditis: cure by medical treatment alone.
    The Journal of infection, 1997, Volume: 35, Issue:1

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost

1997
A case report of Candida parapsilosis endocarditis.
    The Journal of heart valve disease, 1998, Volume: 7, Issue:2

    Topics: Antifungal Agents; Aortic Valve; Aortic Valve Stenosis; Candidiasis; Catheterization, Central Venous

1998
[Successful medical treatment of Candida tropicalis in prosthetic valve endocarditis].
    Medicina, 1998, Volume: 58, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prost

1998
Unfortunate in vitro selection of resistant Candida albicans with severe clinical consequences.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:4

    Topics: Amphotericin B; Animals; Antifungal Agents; Aortic Valve; Aortic Valve Insufficiency; Candida albica

1998
Efficacies of high-dose fluconazole plus amphotericin B and high-dose fluconazole plus 5-fluorocytosine versus amphotericin B, fluconazole, and 5-fluorocytosine monotherapies in treatment of experimental endocarditis, endophthalmitis, and pyelonephritis d
    Antimicrobial agents and chemotherapy, 1999, Volume: 43, Issue:12

    Topics: Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Creatinine; Endocarditis;

1999
Medical treatment of a pacemaker endocarditis due to Candida albicans and to Candida glabrata.
    The Journal of infection, 2000, Volume: 41, Issue:2

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candidiasis; Endocarditis; Fa

2000
Fluconazole plus cyclosporine: a fungicidal combination effective against experimental endocarditis due to Candida albicans.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:11

    Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Cyclosporine; Disease Models, Animal; Dru

2000
Candida endocarditis in a premature infant.
    Journal of perinatal medicine, 2000, Volume: 28, Issue:5

    Topics: Candida albicans; Candidiasis; Endocarditis; Fatal Outcome; Fluconazole; Humans; Infant, Newborn; In

2000
Impact of the order of initiation of fluconazole and amphotericin B in sequential or combination therapy on killing of Candida albicans in vitro and in a rabbit model of endocarditis and pyelonephritis.
    Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:2

    Topics: Amphotericin B; Animals; Antifungal Agents; Area Under Curve; Candida albicans; Endocarditis; Flucon

2001
Fungal left ventricular assist device endocarditis.
    The Annals of thoracic surgery, 2001, Volume: 71, Issue:2

    Topics: Amphotericin B; Combined Modality Therapy; Device Removal; Drug Therapy, Combination; Endocarditis;

2001
Isolated tricuspid valve endocarditis due to Candida parapsilosis associated with long-term central venous catheter implantation.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:5

    Topics: Aged; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Echocardiogra

2001
Candida albicans spinal epidural abscess secondary to prosthetic valve endocarditis.
    Diagnostic microbiology and infectious disease, 2001, Volume: 40, Issue:3

    Topics: Amphotericin B; Candida albicans; Candidiasis; Endocarditis; Epidural Abscess; Female; Fluconazole;

2001
Candida albicans endocarditis diagnosed by PCR-based molecular assay in a critically ill pediatric patient.
    Scandinavian journal of infectious diseases, 2002, Volume: 34, Issue:2

    Topics: Antifungal Agents; Candida albicans; Candidiasis; Child, Preschool; Critical Illness; Down Syndrome;

2002
Candida parapsilosis: two cases of endocarditis in association with the Toronto stentless porcine valve.
    The Journal of infection, 2002, Volume: 44, Issue:3

    Topics: Aged; Aged, 80 and over; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis; Endocardi

2002
Candidal mitral endocarditis and long-term treatment with fluconazole in a patient with human immunodeficiency virus infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 15, Issue:6

    Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; HIV Infections; Humans

1992
Fluconazole treatment of catheter-related right-sided endocarditis caused by Candida albicans and associated with endophthalmitis and folliculitis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1992, Volume: 14, Issue:2

    Topics: Adult; Antibodies, Fungal; Antigens, Fungal; Candida albicans; Candidiasis; DNA Fingerprinting; DNA,

1992
[A case of Candida albicans endocarditis with impaired lung function].
    Kansenshogaku zasshi. The Journal of the Japanese Association for Infectious Diseases, 1992, Volume: 66, Issue:4

    Topics: Candidiasis; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Lung Diseases; Male; Middle

1992
Long-term survival of a patient with prosthetic valve endocarditis due to Trichosporon beigelii.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:9

    Topics: Amphotericin B; Endocarditis; Fluconazole; Heart Valve Prosthesis; Humans; Male; Middle Aged; Mycose

1991
Fluconazole therapy of candidal native valve endocarditis.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1991, Volume: 10, Issue:5

    Topics: Candidiasis; Endocarditis; Fluconazole; Humans; Lung Diseases, Obstructive; Male; Middle Aged

1991
Candidal endocarditis and treatment with fluconazole and granulocyte-macrophage colony-stimulating factor.
    Annals of internal medicine, 1990, Jun-15, Volume: 112, Issue:12

    Topics: Adult; Candidiasis; Colony-Stimulating Factors; Drug Therapy, Combination; Endocarditis; Fluconazole

1990
Fluconazole in the treatment of candidal prosthetic valve endocarditis.
    BMJ (Clinical research ed.), 1988, Jul-16, Volume: 297, Issue:6642

    Topics: Adult; Candidiasis; Endocarditis; Female; Fluconazole; Heart Valve Prosthesis; Humans; Mitral Valve;

1988